Researchers at the University of Alabama at Birmingham are working to better understand ALS and find new ways to slow or stop the disease.

Experimental therapy RT1999 will soon be tested in the UK EXPERTS-ALS platform trial designed to rapidly screen potential ALS treatments.

These included statins, prescribed to treat high cholesterol, and alpha blockers, also known as alpha adrenergic receptor ...

A Lawrence Livermore National Laboratory (LLNL)-led team of scientists and computational engineers using one of the largest electronic health record datasets ever assembled for ALS has identified ...

Fat-based vesicles help deliver GM1 to the brain, improving movement and extending survival in mouse models of ALS, a study finds.

Spain has begun using a new genetic ALS therapy that targets the SOD1 mutation and may slow nerve damage in patients with this rare condition.

Yentli Soto Albrecht has a rare genetic form of ALS and is working on research at Penn that could one day prove life-saving.

Positive data from EXPERTS-ALS could accelerate RT1999 towards a registration trial; RT1999 to be presented as a poster ...

Researchers are to examine whether or not cheap cholesterol-busting statins could help people with motor neurone disease (MND) live longer. People with the progressive neurodegenerative disease ...

The cheap and commonly prescribed drug could be used to 'prolong survival' for MND patients ...

Keros Therapeutics, Inc. ('Keros” or the 'Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on ...

White House officials attributed the red rash on President Donald Trump’s neck to a preventative skin treatment amid ongoing questions about his overall health.